Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Rural health sign | Image credit: BJP7images - stock.adobe.com

FQHCs Show Low Engagement in Hypertension, Diabetes Trials

By Pearl Steinzor

April 15th 2025

A new review finds federally qualified health centers (FQHCs) are underutilized in hypertension and type 2 diabetes clinical research, despite their potential to improve trial diversity.

AI representation of housing stability | Image credit: GoldPumaze - stock.adobe.com

Housing Instability Linked to Worse Type 2 Diabetes Outcomes

By Pearl Steinzor

April 14th 2025

Diabetes concept | Image credit: Sherry Young - stock.adobe.com

GLP-1 RAs, SGLT2 Inhibitors Associated With Reduced MACE, HHF in Patients With Diabetes

By Pearl Steinzor

April 9th 2025

AJMC

The Role of Advanced Technologies in Improving Diabetes Outcomes

By David G. Marrero, PhD
Christopher G. Parkin, MS

April 7th 2025

Diabetes - Vitalii Vodolazskyi - stock.adobe.com.jpg

More Than 250 Million Individuals Unaware They Have Diabetes

By Pearl Steinzor

April 7th 2025

More News

February 20th 2015

FDA Authorizes Sale of First Direct-to-Consumer Genetic Test

Developed by the company 23andMe, the test identifies carriers of a gene mutation that could determine the susceptibility of a person's offspring to Bloom Syndrome.

February 19th 2015

Obesity Among Children and Teens Demands Stronger Response, Lancet Authors Find

Mary K. Caffrey

The article was part of a Lancet series which took aim at the "unacceptably slow" response to rising rates of childhood obesity, and the effects not only on health but also on its social and economic effects on children. Authors called on nations to rein in marketing aimed at children.

February 17th 2015

Improving Medication Understanding Among Latinos Through Illustrated Medication Lists

Arun Mohan, MD, MBA M. Brian Riley, MA Brian Schmotzer, MS Dane R. Boyington, PhD Sunil Kripalani, MD, MSc

A randomized controlled trial found that plain-language, illustrated medication lists improved medication understanding among Latinos.

February 14th 2015

Managed Care Minute: February 14, 2015

A one-minute look at managed care news during the week of February 9, 2015, including an announcement of a new Affordable Care Initiative and a potential change to recommended dietary guidelines.

February 13th 2015

Relationship of Diabetes Complications Severity to Healthcare Utilization and Costs Among Medicare Advantage Beneficiaries

Leslie Hazel-Fernandez, PhD, MPH Yong Li, PhD Damion Nero, PhD Chad Moretz, ScD S. Lane Slabaugh, PharmD, MBA Yunus Meah, PharmD Jean Baltz, MMSc, MSW Nick C. Patel, PharmD, PhD Jonathan R. Bouchard, MS, RPh

This retrospective cohort study in a Medicare Advantage population posits that type 2 diabetes mellitus complications pose an excess burden on healthcare resource use and related costs.

Segment 12: A New Precedent for Healthcare

February 12th 2015

Segment 12: A New Precedent for Healthcare

The situation with hepatitis C drug costs is setting an interesting precedent for the rest of healthcare and one that needs to be watched closely, according to Keith Hoffman, PhD.

February 11th 2015

Report Says US Dietary Panel Poised to Drop Warning on Cholesterol

Mary K. Caffrey

If the Dietary Guidelines Advisory Committee drops cholesterol from the list of "nutrients of concern," it will be consistent with a 2013 task force finding as well as the panel's focus on dietary patterns, or the mix of foods that Americans eat and their effect on population health.

February 10th 2015

Switching from Multiple Daily Injections to CSII Pump Therapy: Insulin Expenditures in Type 2 Diabetes

Guy David, PhD Max Gill, MBA, Candace Gunnarsson, EdD Jeff Shafiroff, PhD Steven Edelman, MD

The effect of switching from multiple daily insulin injections to an insulin pump on insulin and other diabetic drug expenditures in type 2 diabetes.

February 10th 2015

JAMA Meta-Analysis Confirms Link Between Blood Pressure Treatment, Long-Term Survival for T2DM Patients

Mary K. Caffrey

An editorial accompanying the meta-analysis discussed the challenges physicians face when evaluating individual patient needs against guidelines. In the United States, the movement toward reimbursement based on population health measures has raised questions about whether it makes sense for patients to be given multiple medications to achieve small improvements toward targets. Results must be weighed against increased side affects or large out-of-pocket expenditures.

February 9th 2015

Only Some Chronic Diseases Benefit from Disease Management Program

Laura Joszt, MA

A disease management program at the University of Minnesota revealed only some targeted chronic diseases benefitted from the program while others were unaffected.

February 5th 2015

FDA Commissioner Hamburg Stepping Down

After nearly 6 years overseeing public health initiatives, Margaret Hamburg, MD, commissioner of the FDA will be stepping down, according to various sources.

February 4th 2015

FDA Announces Measure to Ease Patient Access to Investigational Drugs

In his blog post on FDAVoice, Peter Lurie MD, MPH, associate FDA commissioner for public health strategy and analysis, announced the introduction of a draft form and a draft guideline that can be used by a physician to request access to an experimental drug or biological product that is still under development.

February 3rd 2015

AHRQ Seeks Research Funds for Multiple Chronic Conditions, Opioid Abuse, Volume-to-Value in FY 2016 Budget

Mary K. Caffrey

The Agency for Healthcare Research and Quality (AHRQ) is a comparatively small part of the federal budget, but its research priorities for FY 2016 affect areas that consume huge sums.

February 2nd 2015

Lilly's Glyxambi, First-in-Class Combination Pill, Approved for T2DM

The dual inhibitor tablet, a combination of an SGLT-2 inhibitor and a DPP-4 inhibitor, is expected to stimulate the pancreas to produce more insulin and stimulate the liver to produce less glucose, and also prevent glucose reabsorption.

February 2nd 2015

California Tightfisted on Diabetes Prevention Programs, Says State Auditor

Although estimates suggest more than 8% in the state suffer from diabetes, federal budge cuts have been partly responsible for the lack of funding.

February 1st 2015

Telephone Intervention Does Not Reduce Nonadherence

Laura Joszt, MA

Addressing primary medication nonadherence through a telephonic intervention from the physicians office was not any more successful than the usual phone calls from the pharmacy.

January 28th 2015

HHS Cheers as ACA Sign-Ups Pass 9 Million Mark, but Here's the Catch: 6.2 Million Could Lose Subsidies in Court Case

Mary K. Caffrey

Meeting enrollment goals for the Affordable Care Act proved the easy part for the HHS in 2015. The hard part will come March 4, 2015, when the US Supreme Court will hear a case that could eliminate financial subsidies for millions who signed up, putting their health coverage at risk.

January 24th 2015

FDA Approves Dexcom's Continuous Glucose Monitoring Mobile App

The Share system has been classified as a novel but low-to-moderate risk device, exempt from the requirement for premarket submissions.

January 23rd 2015

Getting CGM Covered by Medicare Still on the Agenda

Mary K. Caffrey

January 23rd 2015

Race and Gender, Additional Risk Factors in Diabetes for Night-Shift Workers, Study Finds

Surabhi Dangi-Garimella, PhD

January 23rd 2015

Liraglutide Approved Under New Name to Treat Obesity

Mary K. Caffrey

January 23rd 2015

A Look Beyond Findings on Telephone Intervention Reveals Why Having Data Matters

Mary K. Caffrey

January 23rd 2015

School Lunch Changes for 2015 May Be Just the Start of Rollback

Mary K. Caffrey

January 21st 2015

Join Us in Boston for Patient-Centered Diabetes Care 2015

Robert A. Gabbay, MD, PhD, FACP

January 21st 2015

For Staying Power, Diabetes Interventions May Need a Hands-on Element

January 21st 2015

Patient Adherence and CMS Reimbursement Policies for Combination Oral Anti-Diabetic Therapies

January 21st 2015

On the Horizon in Diabetes Therapy: A Delivery System That Doesn't Rely on the Patient

January 21st 2015

Automated Detection of Retinal Disease

Lorens A. Helmchen, PhD Harold P. Lehmann, MD, PhD Michael D. Abràmoff, MD, PhD

With diabetes rates projected to rise sharply, automated retinal screening may represent an attractive low-cost option to meet the growing demand for routine screening services.

January 20th 2015

A Look at the Unhealthiness of Sitting, and a Call for More Research on Its Effects

Mary K. Caffrey

The meta-analysis published today and an accompanying editorial should serve as a wake-up call for healthcare organizations about the costs of caring for aging populations that have spent much of their lives behind desks and watching TV.

January 20th 2015

Celebrating Our 20th Anniversary

A. Mark Fendrick, MD Michael E. Chernew, PhD

The founding mission of AJMC was to bring the best available and most relevant evidence regarding efficient clinical and managerial practice to a broad spectrum of healthcare stakeholders-a mission that remains unchanged to this day.

...

76 77 78 79 80 81 82 83 84

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions